Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Mar 26, 2019 4:35 PM EDT
Oligonucleotide & Precision Therapeutics (OPT) Congress
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “siRNA Clinical Development Based on the TRiMTM Platform”
Cambridge, MA
Mar 27 - Mar 30, 2019
CSHL Meeting: RNA & Oligonucleotide Therapeutics
Dr. Hamilton will deliver an oral presentation titled, “Cardiovascular and lipid disorders - A next frontier for TRiMTM RNAi”
Cold Spring Harbor, NY
Apr 3, 2019 8:00 AM EDT
AACR Annual Meeting 2019
So Wong, Ph.D., Arrowhead’s director of oncology, will deliver a poster presentation titled, “Optimizing the potency and dosing design for ARO-HIF2: An RNAi therapeutic for clear cell renal cell carcinoma”
Apr 10, 2019
The EASL International Liver Congress 2019

Oral Presentation:
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg <100 IU/mL threshold

  • Presentation Reference: PS-080
  • Session: Parallel session: Hepatitis B - drug development
  • Date and Time: April 12, 2019 at 5:45 p.m. CET
  • Authors: Man-Fung Yuen, et al.

Poster Presentation:
Reduction of hepatic Z-alpha1 antitrypsin by RNA interference (RNAi) prevents and reverses liver disease including hepatic mitochondrial injury in the PiZ mouse model

  • Presentation Reference: FRI-446
  • Session: Poster: Rare liver diseases (including pediatric and genetic)
  • Session Date and Time: April 12, 2019 from 9 a.m. to 5 p.m. CET
  • Authors: Christine Wooddell, et al.
Archived Events
Date Event Details
Feb 23 - Feb 24, 2016 12:00 AM EST
2016 RBC Capital Markets' Global Healthcare Conference
New York
Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, and David Lewis, Ph.D., Arrowhead chief scientific officer

February 23, 9:30 a.m. EST – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, and David Lewis, Ph.D., Arrowhead chief scientific officer, will participate in a fireside chat with Michael Yee, managing director – biotechnology equity research, RBC Capital Markets

Feb 20 - Feb 24, 2016 12:00 AM EST
25th Conference of the Asian Pacific Association for the Study of the Liver
Tokyo
Man-Fung Yuen, M.D., Ph.D.

February 22, 1:30 p.m. JST – Man-Fung Yuen, M.D., Ph.D., chair of gastroenterology and hepatology, The University of Hong Kong, and deputy chief of service, Queen Mary Hospital department of medicine, Hong Kong, and coauthors, will deliver an oral presentation titled, “Effective Inhibition of cccDNA Derived mRNA/Viral Antigens and Tolerability with ARC-520

Feb 9, 2016 4:30 PM EST
Arrowhead Fiscal 2016 First Quarter Results
Dec 14, 2015 1:30 PM PST
Arrowhead Fiscal 2015 Year End Results
Dec 6 - Dec 10, 2015 12:00 AM EST
HEP DART 2015
Wailea, Hawaii

December 8, 6:40 p.m. HST – Bruce Given, M.D., Arrowhead chief operating officer, will deliver an oral presentation titled, “New insights on HBV biology from the ARC-520 development program

December 8, 4:00 - 5:30 p.m. HST – Christine Wooddell, Ph.D., Arrowhead group leader will deliver a poster presentation titled, “Sustained reduction in HBsAg, HBV DNA and HBeAg seroconversion in a chronically HBV-infected chimpanzee treated with nucleoside analog/ARC-520 combination therapy

Dec 1 - Dec 2, 2015 12:00 AM EST
Piper Jaffray 27th Annual Healthcare Conference
New York

December 2, 3:00 p.m. EST – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, will present a company overview in a fireside chat with Ted Tenthoff, senior research analyst, Piper Jaffray

Nov 18 - Nov 19, 2015 12:00 AM EST
Jefferies Autumn 2015 Global Healthcare Conference
London, UK

November 19, 2:40 p.m. GMT – Chris Anzalone, Ph.D., Arrowhead president and chief executive officer, will present a company overview

Nov 17, 2015 8:00 AM PST
The Liver Meeting 2015&reg;, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

November 17, 8:00 a.m. - 12:00 p.m. PST - Christine Wooddell, Ph.D., group leader will deliver a poster presentation titled, "Monthly dosing of ARC-520 in chronically hepatitis B virus infected chimpanzees produces rapid, deep and durable reductions in circulating viral antigens"

Nov 16, 2015 6:30 PM PST
The Liver Meeting 2015&reg;, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

November 16, 6:30 p.m. PST - Arrowhead management will host an Analyst and Investor Reception to discuss ARC-520 and key data being presented at the conference

Nov 16, 2015 8:00 AM PST
The Liver Meeting 2015&reg;, 66th Annual Meeting of the American Association for the Study of Liver Disease (AASLD)

November 16, 8:00 a.m. - 5:30 p.m. PST – Man-Fung Yuen, M.D., Ph.D., chair of gastroenterology and hepatology, The University of Hong Kong, and deputy chief of service, Queen Mary Hospital department of medicine, Hong Kong, will deliver a late-breaking poster presentation titled, “ARC-520 produces deep and durable knockdown of viral antigens and DNA in a phase II study in patients with chronic hepatitis B